Eight new drugs for orphan designation
This article was originally published in Scrip
Executive Summary
The EU's Committee for Orphan Medicinal Products (COMP) adopted eight positive opinions on orphan drug designation – including its 26th and 27th positive opinion for cystic fibrosis, at its July plenary meeting.